Cytokines and adrenal insufficiency

Current Opinion in Endocrinology and Diabetes

Volumn 4, Issue 3, 1997, Pages 194-198

  Papanicolaou, Dimitris A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1842636190     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199706000-00002     Document Type: Article

References (42)

1. Werbel SS, Ober KP: Acute adrenal insufficiency. Endocrinol Metab Clin North Am 1993, 22:303-328.
2. Hench PS, Kendall EC, Slocumb CH, Polley HF: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 1949, 24:181-197.
3. Sauer J, Castren M, Hopfner U, Holsboer F, Stalla GK, Arzt E: Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. J Clin Endocrinol Metab 1996, 81:73-79.
4. Chrousos GP: The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995, 332:1351-1362.
5. Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H: Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988, 155:1459-1463.
6. Lyson K, McCann SM: The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991, 54:262-266.
7. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R: Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 1993, 132:946-952.
8. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77:1690-1694.
9. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci U S A 1994, 91:752-756.
10. Hogevold HE, Kierulf P, Ovstebo R, Reikeras O: Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. Eur J Surg 1992, 158:339-345.
11. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, Lowry SF: Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 1993, 150:1999-2006.
12. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Fuerstenberg RK, Weatherbee JA, Young MR, Nemchausky BM, Scheving LE: Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo 1995, 9:331-339.
13. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP: Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996, 271:E601-E605. This double-blind, placebo-controlled, crossover study addresses the stimulation of endogenous IL-6 during high-intensity exercise. IL-6 induction is attenuated but not abolished if the subjects have been pretreated with glucocorticoids.
14. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP: Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 1996, 81:2303-2306. This is the only study, to date, on the production of inflammatory cytokines in humans in acute glucocorticoid deficiency.
15. Amatruda TT, Hurst MM, D'Esopo ND: Certain endocrine and metabolic facets of the steroid withdrawal syndrome. J Clin Endocrinol Metab 1965, 25:1207-1217.
16. Spath-Schwalbe E, Schrezenmeier H, Bornstein S, Burger K, Porzsolt F, Born J: Endocrine effects of recombinant interleukin 6 in man. Neuroendocrinology 1996, 63:237-243.
17. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP: Dose-effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997, in press.
18. Gauldie J, Richards C, Baumann H: IL6 and the acute phase reaction. Res Immunol 1992, 143:755-759.
19. Rothwell NJ: Cytokines and thermogenesis. Int J Obes Relat Metab Disord 1993, 17(suppl 3):S98-101; discussion 115.
20. Sonti G, Ilyin SE, Plata-Salaman CR: Anorexia induced by cytokine interactions at pathophysiological concentrations. Am J Physiol 1996, 270:R1394-R1402.
21. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997, 82:1313-1316.
22. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793. An excellent review of the Th1/Th2 system.
23. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM: Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN and TNF-alpha in human peripheral blood. Cytokine 1995, 7:815-822. In this study a novel and very promising method, the ELISPOT, is used for the analysis of spontaneous cytokine production by human peripheral blood mononuclear cells.
24. Seder RA, Gazzinelli R, Sher A, Paul WE: Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci U S A 1993, 90:10188-10192.
25. Ramierz F, Fowell DJ, Puklavec M, Simmonds S, Mason D: Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J Immunol 1996, 156:2406-2412. This is an in vitro study that examines the effects of glucocorticoids on the Th1/Th2 balance.
26. Hohagen F, Timmer J, Weyerbrock A, Fritsch-Montero R, Ganter U, Krieger S, Berger M, Bauer J: Cytokine production during sleep and wakefulness and its relationship to Cortisol in healthy humans. Neuropsychobiology 1993, 28:9-16.
27. Elenkov IJ, Papanicolaou DA, Wilder RL, Chrousos GP: Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc Assoc Am Physicians 1996, 108:374-381.
28. van der Poll T, Barber AE, Coyle SM, Lowry SF: Hypercortisolemia increases plasma interleukin-10 concentrations during human endo-toxemia - a clinical research center study. J Clin Endocrinol Metab 1996, 81:3604-3606.
29. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, Ledere JL, Vincent JL: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996, 119:76-80.
30. Higgins TL, Calabrese LH, Sheeler LR: Opportunistic infections in patients with ectopic ACTH-secreting tumors. Cleve Clin Q 1982, 49:43-49.
31. Graham BS, Tucker WS Jr: Opportunistic infections in endogenous Cushing's syndrome. Ann Intern Med 1984, 101:334-338.
32. Sauer J, Stalla GK, Muller OA, Arzt E: Inhibition of interleukin-2-mediated lymphocyte activation in patients with Cushing's syndrome: a comparison with hypocortisolemic patients. Neuroendocrinology 1994, 59:144-151.
33. Doppman JL, Oldfield EH, Chrousos GP, Nieman L, Udelsman R, Cutler GB, Loriaux DL: Rebound thymic hyperplasia after treatment of Cushing's syndrome. AJR Am J Roentgenol 1986, 147:1145-1147.
34. Liblau RS, Singer SM, McDevitt HO: Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995, 16:34-38.
35. Hagiwara E, Adams EM, Plotz PH, Klinman DM: Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis. Clin Exp Rheumatol 1996, 14:485-491.
36. Takasu N, Ohara N, Yamada T, Komiya I: Development of autoimmune thyroid dysfunction after bilateral adrenalectomy in a patient with Carney's complex and after removal of ACTH-producing pituitary adenoma in a patient with Cushing's disease. J Endocrinol Invest 1993, 16:697-702.
37. Uthman I, Senecal JL: Onset of rheumatoid arthritis after surgical treatment of Cushing's disease. J Rheumatol 1995, 22:1964-1966.
38. Yakushiji F, Kita M, Hiroi N, Ueshiba H, Monma I, Miyachi Y: Exacerbation of rheumatoid arthritis after removal of adrenal adenoma in Cushing's syndrome. Endocr J 1995, 42:219-223.
39. Smith R, Thomson M: Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium. Baillieres Clin Endocrinol Metab 1991, 5:167-186.
40. Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP: Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 1996, 81:1912-1917.
41. Ostensen M: The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 1992, 28:235-237.
42. Roti E, Emerson CH: Clinical review 29: postpartum thyroiditis. J Clin Endocrinol Metab 1992, 74:3-5.